BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
Number Cited Articles
1
Payam Dindoost, Seyed Mohammad Jazayeri, Seyed Moayed Alavian. Hepatitis B Immune Globulin in Liver Transplantation Prophylaxis: An UpdateHepatitis Monthly 2012; 12(3): 168 doi: 10.5812/hepatmon.5124
2
Patrizia Burra, Giacomo Germani, Renè Adam, Vincent Karam, Alfredo Marzano, Pietro Lampertico, Mauro Salizzoni, Franco Filipponi, Jurgen L. Klempnauer, Denis Castaing, Murat Kilic, Luciano De Carlis, Peter Neuhaus, Sezai Yilmaz, Andreas Paul, Antonio D. Pinna, Andrew K. Burroughs, Francesco P. Russo. Liver transplantation for HBV-related cirrhosis in Europe: An ELTR study on evolution and outcomesJournal of Hepatology 2013; 58(2): 287 doi: 10.1016/j.jhep.2012.10.016
3
Patrizia Burra, Annalisa Masier, Caterina Boldrin, Arianna Calistri, Elisabetta Andreoli, Marco Senzolo, Manuel Zorzi, Dino Sgarabotto, Maria Guido, Umberto Cillo, Daniele Canova, Mauro Bendinelli, Mauro Pistello, Fabrizio Maggi, Giorgio Palù. Torque Teno virus: any pathological role in liver transplanted patients?Transplant International 2008; 21(10): 972 doi: 10.1111/j.1432-2277.2008.00714.x
4
George Mells, James Neuberger. Protocol Liver Allograft BiopsiesTransplantation 2008; 85(12): 1686 doi: 10.1097/TP.0b013e318176b1fd
5
Lydia M. Petrovic. Recurrent diseases following liver transplantationCurrent Opinion in Organ Transplantation 2012; 17(3): 293 doi: 10.1097/MOT.0b013e32835365f6
6
Deirdre A. Kelly, John C. Bucuvalas, Estella M. Alonso, Saul J. Karpen, Upton Allen, Michael Green, Douglas Farmer, Eyal Shemesh, Ruth A. McDonald. Long-term medical management of the pediatric patient after liver transplantation: 2013 practice guideline by the American Association for the Study of Liver Diseases and the American Society of TransplantationLiver Transplantation 2013; 19(8): 798 doi: 10.1002/lt.23697
7
L.H. Katz, M. Paul, D.G. Guy, R. Tur-Kaspa. Prevention of recurrent hepatitis B virus infection after liver transplantation: hepatitis B immunoglobulin, antiviral drugs, or both? Systematic review and meta-analysisTransplant Infectious Disease 2010; 12(4): 292 doi: 10.1111/j.1399-3062.2009.00470.x
8
Experimental and Clinical Transplantation 2015; 13(Suppl 1) doi: 10.6002/ect.mesot2014.O78
9
Jie Chen, Liping Yi, Ji Dong Jia, Hong Ma, Hong You. Hepatitis B immunoglobulins and/or lamivudine for preventing hepatitis B recurrence after liver transplantation: A systematic reviewJournal of Gastroenterology and Hepatology 2010; 25(5): 872 doi: 10.1111/j.1440-1746.2009.06151.x
10
Cristina Rigamonti, Mirella Fraquelli, Anan Judina Bastiampillai, Lucio Caccamo, Paolo Reggiani, Giorgio Rossi, Massimo Colombo, Maria Francesca Donato. Transient elastography identifies liver recipients with nonviral graft disease after transplantation: A guide for liver biopsyLiver Transplantation 2012; 18(5): 566 doi: 10.1002/lt.23391
11
Patrizia Burra, Massimiliano Loreno, Francesco Paolo Russo, Giacomo Germani, Alessandra Galligioni, Marco Senzolo, Umberto Cillo, Giacomo Zanus, Stefano Fagiuoli, Massimo Rugge. Donor livers with steatosis are safe to use in hepatitis C virus-positive recipientsLiver Transplantation 2009; 15(6): 619 doi: 10.1002/lt.21761
12
Stephen E Congly, Kelly W Burak, Carla S Coffin. Hepatitis B immunoglobulin for prevention of hepatitis B virus infection and recurrence after liver transplantationExpert Review of Clinical Immunology 2011; 7(4): 429 doi: 10.1586/eci.11.30
13
Amir Kasraianfard, Kymberly D. Watt, Lance Lindberg, Sophoclis Alexopoulos, Nima Rezaei. HBIG Remains Significant in the Era of New Potent Nucleoside Analogues for Prophylaxis Against Hepatitis B Recurrence After Liver TransplantationInternational Reviews of Immunology 2014; : 1 doi: 10.3109/08830185.2014.921160